Mezzani, I.; Accardo, A.; Bellacchio, E.; Fais, L.; Diaferia, C.; Fierabracci, A.
Preclinical Assessment in Transgenic NOD Mice of a Novel Immunotherapy for Type 1 Diabetes: Lipoplexes Down-Modulate the Murine C1858T Ptpn22 Variant In Vitro. Int. J. Mol. Sci. 2025, 26, 11241.
https://doi.org/10.3390/ijms262311241
AMA Style
Mezzani I, Accardo A, Bellacchio E, Fais L, Diaferia C, Fierabracci A.
Preclinical Assessment in Transgenic NOD Mice of a Novel Immunotherapy for Type 1 Diabetes: Lipoplexes Down-Modulate the Murine C1858T Ptpn22 Variant In Vitro. International Journal of Molecular Sciences. 2025; 26(23):11241.
https://doi.org/10.3390/ijms262311241
Chicago/Turabian Style
Mezzani, Irene, Antonella Accardo, Emanuele Bellacchio, Luca Fais, Carlo Diaferia, and Alessandra Fierabracci.
2025. "Preclinical Assessment in Transgenic NOD Mice of a Novel Immunotherapy for Type 1 Diabetes: Lipoplexes Down-Modulate the Murine C1858T Ptpn22 Variant In Vitro" International Journal of Molecular Sciences 26, no. 23: 11241.
https://doi.org/10.3390/ijms262311241
APA Style
Mezzani, I., Accardo, A., Bellacchio, E., Fais, L., Diaferia, C., & Fierabracci, A.
(2025). Preclinical Assessment in Transgenic NOD Mice of a Novel Immunotherapy for Type 1 Diabetes: Lipoplexes Down-Modulate the Murine C1858T Ptpn22 Variant In Vitro. International Journal of Molecular Sciences, 26(23), 11241.
https://doi.org/10.3390/ijms262311241
